Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Saved in:
| Title: | Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study. |
|---|---|
| Authors: | Oh DY; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea. Electronic address: ohdoyoun@snu.ac.kr., He AR; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Bouattour M; Assistance Publique-Hôpitaux de Paris Hôpital Beaujon, Paris, France., Okusaka T; National Cancer Center Hospital, Tokyo, Japan., Qin S; Cancer Center of Nanjing, Jinling Hospital, Nanjing, China., Chen LT; Kaohsiung Medical University Hospital and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan., Kitano M; Wakayama Medical University, Wakayama, Japan., Lee CK; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Kim JW; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea., Chen MH; Taipei Veterans General Hospital, Taipei City, Taiwan., Suksombooncharoen T; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Ikeda M; National Cancer Center Hospital East, Kashiwa, Japan., Lee MA; Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Chen JS; Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan City, Taiwan., Potemski P; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN, USA., Ostwal V; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Tanasanvimon S; Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand., Morizane C; National Cancer Center Hospital, Tokyo, Japan., Zaucha RE; Medical University of Gdańsk, Gdańsk, Poland., McNamara MG; Division of Cancer Sciences, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Avallone A; Istituto Nazionale Tumori-IRCCS Fondazione G Pascale, Naples, Italy., Cundom JE; Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina., Breder V; N N Blokhin National Medical Research Center of Oncology, Moscow, Russia., Tan B; Washington University School of Medicine, St Louis, MO, USA., Shimizu S; Saitama Cancer Center, Kita-Adachi-Gun, Saitama, Japan., Tougeron D; Poitiers University Hospital, Poitiers, France., Evesque L; Centre Antoine Lacassagne, Nice, France., Petrova M; MHAT Nadezhda, Sofia, Bulgaria., Zhen DB; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Gillmore R; Royal Free Hospital, London, UK., Gupta VG; Artemis Hospitals, Gurugram, India., Dayyani F; University of California, Irvine, CA, USA., Park JO; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA., Rey F; Centro de Investigación y Desarrollo Oncológico, Clínica CIDO, Temuco, Chile., Kim H; AstraZeneca, Osaka, Japan., Wang J; AstraZeneca, New York, NY, USA., Morgan C; AstraZeneca, Gaithersburg, MD, USA., Rokutanda N; AstraZeneca, Gaithersburg, MD, USA., Żotkiewicz M; AstraZeneca, Warsaw, Poland., Vogel A; Toronto General Hospital, University Health Network and Princess Margaret Cancer Center, Toronto, ON, Canada; Hannover Medical School, Hannover, Germany., Valle JW; Division of Cancer Sciences, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK; Cholangiocarcinoma Foundation, Herriman, UT, USA. |
| Source: | The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Aug; Vol. 9 (8), pp. 694-704. Date of Electronic Publication: 2024 May 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38823398 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Oh+DY%22">Oh DY</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea. Electronic address: ohdoyoun@snu.ac.kr.<br /><searchLink fieldCode="AU" term="%22He+AR%22">He AR</searchLink>; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Bouattour+M%22">Bouattour M</searchLink>; Assistance Publique-Hôpitaux de Paris Hôpital Beaujon, Paris, France.<br /><searchLink fieldCode="AU" term="%22Okusaka+T%22">Okusaka T</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Qin+S%22">Qin S</searchLink>; Cancer Center of Nanjing, Jinling Hospital, Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Chen+LT%22">Chen LT</searchLink>; Kaohsiung Medical University Hospital and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kitano+M%22">Kitano M</searchLink>; Wakayama Medical University, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JW%22">Kim JW</searchLink>; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Chen+MH%22">Chen MH</searchLink>; Taipei Veterans General Hospital, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Suksombooncharoen+T%22">Suksombooncharoen T</searchLink>; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.<br /><searchLink fieldCode="AU" term="%22Ikeda+M%22">Ikeda M</searchLink>; National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Lee+MA%22">Lee MA</searchLink>; Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Chen+JS%22">Chen JS</searchLink>; Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Potemski+P%22">Potemski P</searchLink>; Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Ostwal+V%22">Ostwal V</searchLink>; Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.<br /><searchLink fieldCode="AU" term="%22Tanasanvimon+S%22">Tanasanvimon S</searchLink>; Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Morizane+C%22">Morizane C</searchLink>; National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Zaucha+RE%22">Zaucha RE</searchLink>; Medical University of Gdańsk, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22McNamara+MG%22">McNamara MG</searchLink>; Division of Cancer Sciences, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Avallone+A%22">Avallone A</searchLink>; Istituto Nazionale Tumori-IRCCS Fondazione G Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Cundom+JE%22">Cundom JE</searchLink>; Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Breder+V%22">Breder V</searchLink>; N N Blokhin National Medical Research Center of Oncology, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Tan+B%22">Tan B</searchLink>; Washington University School of Medicine, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Shimizu+S%22">Shimizu S</searchLink>; Saitama Cancer Center, Kita-Adachi-Gun, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Tougeron+D%22">Tougeron D</searchLink>; Poitiers University Hospital, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Evesque+L%22">Evesque L</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Petrova+M%22">Petrova M</searchLink>; MHAT Nadezhda, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Zhen+DB%22">Zhen DB</searchLink>; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Gillmore+R%22">Gillmore R</searchLink>; Royal Free Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Gupta+VG%22">Gupta VG</searchLink>; Artemis Hospitals, Gurugram, India.<br /><searchLink fieldCode="AU" term="%22Dayyani+F%22">Dayyani F</searchLink>; University of California, Irvine, CA, USA.<br /><searchLink fieldCode="AU" term="%22Park+JO%22">Park JO</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Buchschacher+GL+Jr%22">Buchschacher GL Jr</searchLink>; Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rey+F%22">Rey F</searchLink>; Centro de Investigación y Desarrollo Oncológico, Clínica CIDO, Temuco, Chile.<br /><searchLink fieldCode="AU" term="%22Kim+H%22">Kim H</searchLink>; AstraZeneca, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; AstraZeneca, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+C%22">Morgan C</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rokutanda+N%22">Rokutanda N</searchLink>; AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Żotkiewicz+M%22">Żotkiewicz M</searchLink>; AstraZeneca, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Vogel+A%22">Vogel A</searchLink>; Toronto General Hospital, University Health Network and Princess Margaret Cancer Center, Toronto, ON, Canada; Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Valle+JW%22">Valle JW</searchLink>; Division of Cancer Sciences, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK; Cholangiocarcinoma Foundation, Herriman, UT, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690683%22">The lancet. Gastroenterology & hepatology</searchLink> [Lancet Gastroenterol Hepatol] 2024 Aug; Vol. 9 (8), pp. 694-704. <i>Date of Electronic Publication: </i>2024 May 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101690683 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-1253 (Electronic) <i>NLM ISO Abbreviation: </i>Lancet Gastroenterol Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38823398 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2468-1253(24)00095-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 694 Titles: – TitleFull: Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Oh DY – PersonEntity: Name: NameFull: He AR – PersonEntity: Name: NameFull: Bouattour M – PersonEntity: Name: NameFull: Okusaka T – PersonEntity: Name: NameFull: Qin S – PersonEntity: Name: NameFull: Chen LT – PersonEntity: Name: NameFull: Kitano M – PersonEntity: Name: NameFull: Lee CK – PersonEntity: Name: NameFull: Kim JW – PersonEntity: Name: NameFull: Chen MH – PersonEntity: Name: NameFull: Suksombooncharoen T – PersonEntity: Name: NameFull: Ikeda M – PersonEntity: Name: NameFull: Lee MA – PersonEntity: Name: NameFull: Chen JS – PersonEntity: Name: NameFull: Potemski P – PersonEntity: Name: NameFull: Burris HA 3rd – PersonEntity: Name: NameFull: Ostwal V – PersonEntity: Name: NameFull: Tanasanvimon S – PersonEntity: Name: NameFull: Morizane C – PersonEntity: Name: NameFull: Zaucha RE – PersonEntity: Name: NameFull: McNamara MG – PersonEntity: Name: NameFull: Avallone A – PersonEntity: Name: NameFull: Cundom JE – PersonEntity: Name: NameFull: Breder V – PersonEntity: Name: NameFull: Tan B – PersonEntity: Name: NameFull: Shimizu S – PersonEntity: Name: NameFull: Tougeron D – PersonEntity: Name: NameFull: Evesque L – PersonEntity: Name: NameFull: Petrova M – PersonEntity: Name: NameFull: Zhen DB – PersonEntity: Name: NameFull: Gillmore R – PersonEntity: Name: NameFull: Gupta VG – PersonEntity: Name: NameFull: Dayyani F – PersonEntity: Name: NameFull: Park JO – PersonEntity: Name: NameFull: Buchschacher GL Jr – PersonEntity: Name: NameFull: Rey F – PersonEntity: Name: NameFull: Kim H – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Morgan C – PersonEntity: Name: NameFull: Rokutanda N – PersonEntity: Name: NameFull: Żotkiewicz M – PersonEntity: Name: NameFull: Vogel A – PersonEntity: Name: NameFull: Valle JW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2468-1253 Numbering: – Type: volume Value: 9 – Type: issue Value: 8 Titles: – TitleFull: The lancet. Gastroenterology & hepatology Type: main |
| ResultId | 1 |
